Eli Lilly and Company
BTLA agonist antibodies and uses thereof
Last updated:
Abstract:
Antibodies which bind BTLA, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with autoimmune disease including treating lupus.
Status:
Grant
Type:
Utility
Filling date:
17 Feb 2020
Issue date:
26 Jul 2022